Key Record Dates
ClinicalTrials.gov Identifier: | NCT03157128 |
---|---|
Brief Title: | A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (LIBRETTO-001) |
First Submitted : | May 9, 2017 |
First Submitted that Met QC Criteria : | May 15, 2017 |
First Posted : | May 17, 2017 |
Last Update Submitted that Met QC Criteria : | March 1, 2024 |
Last Update Posted : | March 4, 2024 |